Evidence map›Paper›PMID 28508064›Full record

ArticleScience advances2017

Fibulin-4 is essential for maintaining arterial wall integrity in conduit but not muscular arteries.

Carmen M Halabi, Thomas J Broekelmann, Michelle Lin, Vivian S Lee, Mon-Li Chu, Robert P Mecham

Abstract read
In one paragraph

Article in Science advances, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Protective Role of Endothelial Fibulin-4 in Valvulo-Arterial Integrity.Journal of the American Heart Association · 2023
    Article
  17. Review
  18. Review
  19. Review
  20. Dual role of endothelialScience translational medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Carmen M HalabiDivision of Nephrology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Thomas J BroekelmannDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Michelle LinDivision of Nephrology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Vivian S LeeDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0003-0578-7781
Mon-Li ChuDepartment of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Robert P MechamDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Funding

Training of the Pediatric Physician-ScientistT32HD043010 · NICHD · WASHINGTON UNIVERSITY · PI MARK E. LOWE · 2002 to 2026
$6.4M
Child Health Research CenterK12HD076224 · NICHD · WASHINGTON UNIVERSITY · PI MARK E. LOWE · 2013 to 2026
$6.2M
Pediatric Cardiovascular and Pulmonary Research Training Program.T32HL125241 · NHLBI · WASHINGTON UNIVERSITY · PI Juliane Bubeck Wardenburg, Kory J. Lavine · 2015 to 2026
$4.1M
ASSEMBLY OF LUNG ELASTINR01HL053325 · NHLBI · WASHINGTON UNIVERSITY · PI MECHAM, ROBERT P. · 1995 to 2019
$3.6M
VESSEL STIFFENING, HYPERTENSION, AND VASCULAR EXTRACELLULAR MATRIXR01HL105314 · NHLBI · WASHINGTON UNIVERSITY · PI MECHAM, ROBERT P., WAGENSEIL, JESSICA · 2010 to 2018
$3.2M
INTERDISCIPLINARY TRAINING IN MECHANOBIOLOGY FROM NM TO CMT32EB018266 · NIBIB · WASHINGTON UNIVERSITY · PI BAYLY, PHILIP V · 2014 to 2018
$987k
Lysyl Oxidase Mutations in Cardiovascular DiseaseF31HL136073 · NHLBI · WASHINGTON UNIVERSITY · PI LEE-KIM, VIVIAN · 2017 to 2018
$34k
NHLBI NIH HHS F31 HL136073NHLBI NIH HHS R01 HL053325NHLBI NIH HHS R01 HL105314NHLBI NIH HHS T32 HL125241NIBIB NIH HHS T32 EB018266NICHD NIH HHS K12 HD076224NICHD NIH HHS T32 HD043010
6 · The paper itself

Abstract

Homozygous or compound heterozygous mutations in fibulin-4 (

Indexed as

AnimalsAortaAortic AneurysmArteriesCardiovascular SystemCutis LaxaElastic TissueElastinExtracellular Matrix ProteinsFemaleHumansJoint InstabilityMaleMiceMice, Inbred C57BLMutationEFEMP2 protein, humanElastinExtracellular Matrix ProteinsProtein-Lysine 6-Oxidasearterial stiffnessascending aortic aneurysmcutis laxaelastic fiberextracellular matrixFibluin-4

Identifiers

PMID28508064
PMCPMC5415335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.